Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/06/14
End: 12/19/14
Due: 12/19/15
Phase: N/A
Priority: Normal
Start: 03/20/24
End: 03/31/25
Due: 03/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases | NCT04008771 | 2C Tech Corp | user2@example.com | None | 2014-01-06 | 2014-12-19 | 2015-12-19 | - | - | 2025-07-14 |
| Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM) | NCT05841862 | 2C Tech Corp | user2@example.com | None | 2024-03-20 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |